LetterLetter
COVID-19 and IgA Vasculitis
Rujittika Mungmunpuntipantip and Viroj Wiwanitkit
The Journal of Rheumatology December 2022, jrheum.221074; DOI: https://doi.org/10.3899/jrheum.221074
Rujittika Mungmunpuntipantip
Private Academic Consultant, Bangkok, Thailand. University Centre for Research & Development Department of Pharmaceutical Sciences, Chandigarh University Gharuan, Mohali, Punjab, India. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Mungmunpuntipantip, Private Academic Consultant, 111 Bangkok 122, Bangkok 1033000, Thailand. Email: rujittika@gmail.com.
Viroj Wiwanitkit
Private Academic Consultant, Bangkok, Thailand. University Centre for Research & Development Department of Pharmaceutical Sciences, Chandigarh University Gharuan, Mohali, Punjab, India. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Mungmunpuntipantip, Private Academic Consultant, 111 Bangkok 122, Bangkok 1033000, Thailand. Email: rujittika@gmail.com.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
COVID-19 and IgA Vasculitis
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
The Journal of Rheumatology Dec 2022, jrheum.221074; DOI: 10.3899/jrheum.221074